Share Issue News

SAN JOSÉ, Calif.--(BUSINESS WIRE)--Power Integrations (Nasdaq: POWI) today announced that on October 15, 2026 (the Grant Date), it granted a total of 25,325 RSUs and 1,339 PSUs at target to a total of 12 employees who began their employment with Power Integrations in September 2026.The inducement grants were issued pursuant to Power Integrations’ Amended and Restated 2025 Inducement Award Plan. One-fourth (1/4th) of the RSUs will vest on each of the first four anniversaries of the respective Gra...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on October 15, 2026, it granted stock options to purchase shares of common stock to Stephen Aschettino, the Com...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the Company granted inducement equity awards covering an aggregate of 61,020 shares of its common stock to seven newly hired employees, consisting of inducement stock options to purchase an aggregate of 17,461 shares of common stock and inducement restricted stock units, covering an aggregate of 43,559 shares of its common stock. The awards are subject to all terms and conditions and other provisi...

ORANGE COUNTY, Calif.--(BUSINESS WIRE)--Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic”) announced that the Compensation Committee of Virgin Galactic’s Board of Directors approved the grants of time-based inducement restricted stock unit awards covering an aggregate of 48,472 shares of Virgin Galactic common stock to two new non-executive employees, each effective October 15, 2026. The awards were granted under Virgin Galactic’s Second Amended and Restated 2023 Employment Inducem...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leading full-stack quantum platform and foundry, today announced the pricing of a $2.0 billion equity offering. “This investment will accelerate the commercialization of our full-stack quantum platform and is a tremendous vote of confidence in the trailblazing innovation that has defined IonQ,” said Niccolo de Masi, Chairman and CEO of IonQ. “The significance of this raise goes beyond its size — giving IonQ additional strategic flexibilit...

TORONTO--(BUSINESS WIRE)--Roots Corporation (the “Company” or “Roots”) (TSX: ROOT) today announced that at its special meeting (the “Meeting”) of holders (the “Shareholders”) of common shares (the “Shares”) of Roots, Shareholders voted in favour of the special resolution (the “Arrangement Resolution”) approving the previously-announced plan of arrangement under the Canada Business Corporations Act, pursuant to which Marquee Brands LLC, through its strategic operating partner JM&A Design &am...

SAN RAMON, Calif.--(BUSINESS WIRE)--Five9, Inc. (Nasdaq: FIVN) (“Five9” or the “Company”) today announced that on October 12, 2026, the Company granted restricted stock unit awards (“RSUs”) covering an aggregate of 93,116 shares of the Company’s common stock (“Shares”) to five non-executive officer employees (collectively, the “Inducement Awards”). The Compensation Committee of the Board of Directors of the Company approved the grant of the Inducement Awards, which were each offered as a materi...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 45,940 common shares of the Company (the "Options") with effective grant dates of October 13, 2026...

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on October 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 178,580 shares of its common stock to 33 new employees, consisting of inducement stock options to purchase an aggregate of 36,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 142,580 shares of its common stock. These induceme...